Formulation of amphotericin B as nanosuspension for oral administration

International Journal of Pharmaceutics

Volumn 254, Issue 1, 2003, Pages 73-75

  Kayser, O ^a   Olbrich, C ^a   Yardley, V ^c   Kiderlen, A F ^b   Croft, S L ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Amphotericin; Leishmania; Nanosuspension; Oral

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ELECTROLYTE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; FEMALE; GASTROINTESTINAL TRACT; IN VIVO STUDY; INTESTINE FLUID; LEISHMANIA DONOVANI; LIVER; MOUSE; NONHUMAN; PARASITE; PH; PRESSURE; PRIORITY JOURNAL; SPECTROSCOPY; VISCERAL LEISHMANIASIS;

EID: 0037453179     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00686-5     Document Type: Conference Paper

References (6)

1. Arikan S., Rex J.H. Lipid-based antifungal agents: current status. Curr. Pharm. Des. 5:2001;393-415.
2. Croft, S.L., Yardley, V., 1999. Models of visceral leishmaniasis. In: Zak, O., Sande, M. (Eds.), Handbook of Animal Models of Infection. Academic Press, London, pp. 738-787.
3. Kayser O. A new approach for targeting Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications. Int. J. Pharm. 214:2001;83-85.
4. Müller, R.H., Kayser, O., Jacobs, C., 2000. Nanosuspensions for the formulation of poorly soluble drugs - rationale for development and what we can expect for the future. In: Nielloud, F., Marti-Mestres, G. (Eds.), Pharmaceutical emulsions and suspensions. Plenum Press/Marcel Dekker, New York, pp. 383-408.
5. Müller R.H., Peters K. Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique. Int. J. Pharm. 160:1998;229-237.
6. Santangelo R., Paderu P., Delmas G., Chen Z.W., Mannino R., Zarif L., Perlin D.S. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob. Agents Chemother. 44:2000;2356-2360.